■ Market Review

On Oct. 24, CTC BIO (060590) increased 1.75% to 9,860 won (US$8.70). It had declined 12.36% through the past month. Standard deviation, which indicates variableness, records 2% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, since the monthly volatility of CTC BIO was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.1%. By tumbling of stock price, return-on-risk is the lowest among its peer group in spite of low volatility. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -6.0, and thus the industrial comparison performance was not so good.

■ Earnings & Valuation

CTC BIO(060590): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016)

Compared with 4 close competitors with similar market capitalization within its industry, CTC BIO's P/B ratio, a financial ratio of a company's book value, and its P/E ratio, a price-paid ratio of annual net income, are both at a relatively lower level.

Close Compatitors ROE

■ Investor Group

Cumulated shareholdings per investor group (1Mo)  

* Other Investor groups, included as "other corporations", are considered as "Individuals".